SCHEMBL6307948

SCHEMBL6307948

CC1C(=O)N(NC(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)C)c2ccccc2-c2cc(F)ccc21

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 14/20 0.40
CCKAR P32238 2/20 0.36
CCKBR P32239 2/20 0.36
TRPA1 O75762 1/20 0.36
CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6307590 0.93 SCN9A (0.41) SCN9ACCKARCCKBRTRPA1
SCHEMBL8131059 0.92 SCN9A (0.37) SCN9ACCKARCCKBRCA2
SCHEMBL6304730 0.91 SCN9A (0.41) SCN9ACCKARCCKBR
SCHEMBL7568374 0.90 SCN9A (0.39) SCN9ACCKARCCKBRTRPA1CA2
SCHEMBL4424746 0.90 SCN9A (0.39) SCN9ACCKARCCKBRTRPA1CA2
SCHEMBL4418511 0.90 SCN9A (0.39) SCN9ACCKARCCKBRTRPA1CA2
SCHEMBL8140471 0.86 CA2 (0.38) SCN9ACCKARCCKBRCA2
SCHEMBL6307611 0.84 SCN9A (0.42) SCN9ACCKARCCKBR
SCHEMBL8132264 0.81 SCN9A (0.40) SCN9ACCKARCCKBR
SCHEMBL6305882 0.81 PSEN1 (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6958330-B1 Polycyclic α-amino-ε-caprolactams and related compounds ELAN PHARMACEUTICALS, INC. (US) 2005-10-25 US claimed
EP-1042298-A1 POLYCYCLIC ALPHA-AMINO-EPSILON-CAPROLACTAMS AND RELATED COMPOUNDS Elan Pharmaceuticals, Inc. (US) 2000-10-11 EP claimed
WO-1999032453-A1 POLYCYCLIC α-AMINO-⊂-CAPROLACTAMS AND RELATED COMPOUNDS ELAN PHARMACEUTICALS, INC. (US) 1999-07-01 WO claimed
US-6958330-B1 Polycyclic α-amino-ε-caprolactams and related compounds ELAN PHARMACEUTICALS, INC. (US) 2005-10-25 US disclosed